Journal
LUNG CANCER MANAGEMENT
Volume 8, Issue 4, Pages -Publisher
FUTURE MEDICINE LTD
DOI: 10.2217/lmt-2019-0007
Keywords
5-fluorouracil; bevacizumab; carboplatin; cisplatin; gemcitabine; inhalation; lung cancer; nitrocamptothecine; non-small-cell lung cancer; paclitaxel; taxol
Categories
Ask authors/readers for more resources
Lung cancer is still diagnosed at a late stage due to a lack of symptoms. Although there are novel therapies, many patients are still treated with chemotherapy. In an effort to reduce adverse effects associated with chemotherapy, inhaled administration of platinum analogs has been investigated. Inhaled administration is used as a local route in order to reduce the systemic adverse effects; however, this treatment modality has its own adverse effects. In this mini review, we present drugs that were administered as nebulized droplets or dry powder aerosols for non-small-cell lung cancer. We present the adverse effects and methods to overcome them.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available